ES Bensadoun, AK Burke, JC Hogg and CR Roberts
University of British Columbia Pulmonary Research Laboratory, Department of Medicine, University of British Columbia, St. Paul's Hospital, Vancouver, Canada.

This study compares the deposition of proteoglycans in the extracellular matrix of the lung lesions of the adult respiratory distress syndrome (ARDS) and bronchiolitis obliterans organizing pneumonia (BOOP) to those present in idiopathic pulmonary fibrosis (IPF). Tissue from individuals with ARDS (n = 7), BOOP (n = 5), IPF (n = 5), and control subjects (n = 5) was examined for glycosaminoglycans and collagen by histochemistry, and for hyaluronan, versican, decorin, biglycan, Types I and III collagen, type I procollagen and alpha-smooth muscle actin (alpha-SMA) using immunohistochemistry. The results showed that glycosaminoglycan deposition in the lesions of ARDS, BOOP, and IPF corresponded to the deposition of versican. Versican localized to the thickened interstitium in the fibroproliferative phase of ARDS, to the intraluminal buds in BOOP, and to early fibroblast foci in IPF. The versican-rich areas contained little mature collagen, but the myofibroblasts in these areas stained for type I procollagen, suggesting early collagen synthesis, and stained intracellularly for decorin. The localization of versican in ARDS, BOOP, and IPF suggests that this proteoglycan may influence early repair processes in the lung.

This article has been cited by other articles:

				P. A. Singleton, S. M. Dudek, S.-F. Ma, and J. G. N. Garcia Transactivation of Sphingosine 1-Phosphate Receptors Is Essential for Vascular Barrier Regulation: NOVEL ROLE FOR HYALURONAN AND CD44 RECEPTOR FAMILY J. Biol. Chem., November 10, 2006; 281(45): 34381 - 34393. [Abstract] [Full Text] [PDF]

				L. Pini, C. Torregiani, J. G. Martin, Q. Hamid, and M. S. Ludwig Airway remodeling in allergen-challenged Brown Norway rats: distribution of proteoglycans Am J Physiol Lung Cell Mol Physiol, June 1, 2006; 290(6): L1052 - L1058. [Abstract] [Full Text] [PDF]

				C. W. Frevert and P. L. Sannes Matrix proteoglycans as effector molecules for epithelial cell function Eur. Respir. Rev., December 1, 2005; 14(97): 137 - 144. [Abstract] [Full Text] [PDF]

				A. Fust, F. LeBellego, R. V. Iozzo, P. J. Roughley, and M. S. Ludwig Alterations in lung mechanics in decorin-deficient mice Am J Physiol Lung Cell Mol Physiol, January 1, 2005; 288(1): L159 - L166. [Abstract] [Full Text] [PDF]

				Mechanisms and Limits of Induced Postnatal Lung Growth Am. J. Respir. Crit. Care Med., August 1, 2004; 170(3): 319 - 343. [Full Text] [PDF]

				A Scott, K M Khan, C R Roberts, J L Cook, and V Duronio What do we mean by the term "inflammation"? A contemporary basic science update for sports medicine Br. J. Sports Med., June 1, 2004; 38(3): 372 - 380. [Abstract] [Full Text] [PDF]

				S. Potter-Perigo, C. Baker, C. Tsoi, K. R. Braun, S. Isenhath, G. M. Altman, L. C. Altman, and T. N. Wight Regulation of Proteoglycan Synthesis by Leukotriene D4 and Epidermal Growth Factor in Bronchial Smooth Muscle Cells Am. J. Respir. Cell Mol. Biol., January 1, 2004; 30(1): 101 - 108. [Abstract] [Full Text] [PDF]

				M. A. Olman and M. A. Matthay Transforming growth factor-{beta} induces fibrosis in immune cell-depleted lungs Am J Physiol Lung Cell Mol Physiol, September 1, 2003; 285(3): L522 - L526. [Full Text] [PDF]

				C. W. Frevert, M. G. Kinsella, C. Vathanaprida, R. B. Goodman, D. G. Baskin, A. Proudfoot, T. N. C. Wells, T. N. Wight, and T. R. Martin Binding of Interleukin-8 to Heparan Sulfate and Chondroitin Sulfate in Lung Tissue Am. J. Respir. Cell Mol. Biol., April 1, 2003; 28(4): 464 - 472. [Abstract] [Full Text] [PDF]

				N. Venkatesan, P. J. Roughley, and M. S. Ludwig Proteoglycan expression in bleomycin lung fibroblasts: role of transforming growth factor-beta 1 and interferon-gamma Am J Physiol Lung Cell Mol Physiol, October 1, 2002; 283(4): L806 - L814. [Abstract] [Full Text] [PDF]

				S. Santos, V.I. Peinado, J. Ramirez, T. Melgosa, J. Roca, R. Rodriguez-Roisin, and J.A. Barbera Characterization of pulmonary vascular remodelling in smokers and patients with mild COPD Eur. Respir. J., April 1, 2002; 19(4): 632 - 638. [Abstract] [Full Text] [PDF]

				R. Koslowski, U. Pfeil, H. Fehrenbach, M. Kasper, E. Skutelsky, and K-W. Wenzel Changes in xylosyltransferase activity and in proteoglycan deposition in bleomycin-induced lung injury in rat Eur. Respir. J., August 1, 2001; 18(2): 347 - 356. [Abstract] [Full Text] [PDF]

				M. KOLB, P. J. MARGETTS, T. GALT, P. J. SIME, Z. XING, M. SCHMIDT, and J. GAULDIE Transient Transgene Expression of Decorin in the Lung Reduces the Fibrotic Response to Bleomycin Am. J. Respir. Crit. Care Med., March 1, 2001; 163(3): 770 - 777. [Abstract] [Full Text] [PDF]

				R. Al Jamal, P. J. Roughley, and M. S. Ludwig Effect of glycosaminoglycan degradation on lung tissue viscoelasticity Am J Physiol Lung Cell Mol Physiol, February 1, 2001; 280(2): L306 - L315. [Abstract] [Full Text] [PDF]

				T. EBIHARA, N. VENKATESAN, R. TANAKA, and M. S. LUDWIG Changes in Extracellular Matrix and Tissue Viscoelasticity in Bleomycin-induced Lung Fibrosis . Temporal Aspects Am. J. Respir. Crit. Care Med., October 1, 2000; 162(4): 1569 - 1576. [Abstract] [Full Text] [PDF]

				N. VENKATESAN, T. EBIHARA, P. J. ROUGHLEY, and M. S. LUDWIG Alterations in Large and Small Proteoglycans in Bleomycin-Induced Pulmonary Fibrosis in Rats Am. J. Respir. Crit. Care Med., June 1, 2000; 161(6): 2066 - 2073. [Abstract] [Full Text]

				M. Dolhnikoff, J. Morin, P. J. Roughley, and M. S. Ludwig Expression of Lumican in Human Lungs Am. J. Respir. Cell Mol. Biol., October 1, 1998; 19(4): 582 - 587. [Abstract] [Full Text]

				A.-L. A. KATZENSTEIN and J. L. MYERS Idiopathic Pulmonary Fibrosis . Clinical Relevance of Pathologic Classification Am. J. Respir. Crit. Care Med., April 1, 1998; 157(4): 1301 - 1315. [Full Text] [PDF]